Oral immediate release formulations for substituted quinazolinones

• 收藏
• 分享

专利权人:

Resverlogix Corp.

发明人:

Shenoy, Narmada R.

申请号：

AU2012330885

公开号：

AU2012330885A1

申请日:

2012.10.31

申请国别(地区):

AU

年份:

2014

代理人:

摘要：

The present disclosure relates to oral immediate release solid pharmaceutical formulations and the process for their preparation. The present disclosure also provides, in part, methods of using the pharmaceutical formulations for regulating the expression of apolipoprotein A-I (ApoA-I), and their use for the treatment and prevention of cardiovascular disease and related disease states, including cholestrol- or lipid-related disorders, such as atherosclerosis.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/